Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Walter Pouwels"'
Autor:
Linda Smit, Gert J. Ossenkoppele, Gerrit Jan Schuurhuis, Walter Pouwels, Arjo P. Rutten, Marjolein C. Olthof, Fedor Denkers, David C. de Leeuw
XLSX file - 54KB, Genes correlated with microRNA-126 expression in 163 AML patients show overlap with stem cell genes: Genes positively and negatively associated with miR-126 expression in 163 AML patients as published by (34). 854 genes were signifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0be0071c09a534453e4a690227defec8
https://doi.org/10.1158/0008-5472.22400873
https://doi.org/10.1158/0008-5472.22400873
Autor:
Linda Smit, Gert J. Ossenkoppele, Gerrit Jan Schuurhuis, Walter Pouwels, Arjo P. Rutten, Marjolein C. Olthof, Fedor Denkers, David C. de Leeuw
XLSX file - 15KB, MicroRNAs differentially expressed between LSC and HSC (at least 2 out of 3 patients): Upper: MicroRNA expression ratios between CD34+CD38-ALDHlow/dim(LSC) and CD34+CD38-ALDHhigh (HSC) populations obtained from microarray analysis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::205a160304b367da8233636005be81c1
https://doi.org/10.1158/0008-5472.22400879.v1
https://doi.org/10.1158/0008-5472.22400879.v1
Autor:
Linda Smit, Gert J. Ossenkoppele, Gerrit Jan Schuurhuis, Walter Pouwels, Arjo P. Rutten, Marjolein C. Olthof, Fedor Denkers, David C. de Leeuw
PDF file - 93KB, Validation of microarray by qRT-PCR: Surplus RNA from LSC and progenitor populations that remained after array hybridization was used for the validation of the microarray results. MicroRNA expression analysis was performed by qRT-PCR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54b8e2baf628802165bd4cdb64bef018
https://doi.org/10.1158/0008-5472.22400888.v1
https://doi.org/10.1158/0008-5472.22400888.v1
Autor:
Linda Smit, Gert J. Ossenkoppele, Gerrit Jan Schuurhuis, Walter Pouwels, Arjo P. Rutten, Marjolein C. Olthof, Fedor Denkers, David C. de Leeuw
Despite high remission rates after therapy, 60% to 70% of patients with acute myeloid leukemia (AML) do not survive 5 years after their initial diagnosis. The main cause of treatment failures may be insufficient eradication of a subpopulation of leuk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b90833b30d62cbe27366d54f5243b459
https://doi.org/10.1158/0008-5472.c.6505712
https://doi.org/10.1158/0008-5472.c.6505712
Autor:
Linda Smit, Gert J. Ossenkoppele, Gerrit Jan Schuurhuis, Walter Pouwels, Arjo P. Rutten, Marjolein C. Olthof, Fedor Denkers, David C. de Leeuw
XLSX file - 14KB, MicroRNAs differentially expressed between LSC and progenitors (at least 4 out of 6 patients): Upper: MicroRNA expression ratios between CD34+CD38-ALDHlow/dim (LSC) and CD34+CD38+ALDHlow/dim (malignant progenitor) populations obtain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::019666fb44cfba1d1cbae8ef5b62b192
https://doi.org/10.1158/0008-5472.22400882
https://doi.org/10.1158/0008-5472.22400882
Autor:
Linda Smit, Gert J. Ossenkoppele, Gerrit Jan Schuurhuis, Walter Pouwels, Arjo P. Rutten, Marjolein C. Olthof, Fedor Denkers, David C. de Leeuw
XLSX file - 11KB, MicroRNA-126 is highly expressed in core binding factor AML: qRT-PCR results of miR-126 in CD34+CD38-ALDHlow/dim LSC and CD34+CD38+ALDHlow/dim leukemic progenitors in 18 AML patients. Cytogenetics indicates the presence of a CBF kar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0289ab5a2574ac15e921379c7d167de7
https://doi.org/10.1158/0008-5472.22400876
https://doi.org/10.1158/0008-5472.22400876
Autor:
Linda Smit, Gert J. Ossenkoppele, Gerrit Jan Schuurhuis, Walter Pouwels, Arjo P. Rutten, Marjolein C. Olthof, Fedor Denkers, David C. de Leeuw
XLSX file - 9KB, Patient characteristics and stem cell frequencies: Patient characteristics and stem cell frequencies of samples used for miRNA expression profiling using microarray. Molecular aberrancy indicates the aberrancy as detected by routine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2737060d34c085bd0b4b222574dbc027
https://doi.org/10.1158/0008-5472.22400885.v1
https://doi.org/10.1158/0008-5472.22400885.v1
Autor:
Walter Pouwels, Halvard Bonig, Kirsten Langeveld, J.J. Stenzel, Katharina Landwehr, Menno A.W.G. van der Hoorn, Nina Müller, Erhard Seifried
Publikováno v:
Cytotherapy. 20(4)
Background aims For patients needing allogeneic stem cell transplantation but lacking a major histocompatibility complex (MHC)-matched donor, haplo-identical (family) donors may be an alternative. Stringent T-cell depletion required in these cases to
Autor:
Gert J. Ossenkoppele, Arjo P Rutten, Linda Smit, David C. de Leeuw, Marjolein C. Olthof, Gerrit Jan Schuurhuis, Walter Pouwels, Fedor Denkers
Publikováno v:
de Leeuw, D C, Denkers, F, Olthof, M C, Rutten, A P, Pouwels, W, Schuurhuis, G J, Ossenkoppele, G J & Smit, L 2014, ' Attenuation of microRNA-126 Expression That Drives CD34(+)38 Stem/Progenitor Cells in Acute Myeloid Leukemia Leads to Tumor Eradication ', Cancer Research, vol. 74, no. 7, pp. 2094-2105 . https://doi.org/10.1158/0008-5472.CAN-13-1733
Cancer Research, 74(7), 2094-2105. American Association for Cancer Research Inc.
Cancer Research, 74(7), 2094-2105. American Association for Cancer Research Inc.
Despite high remission rates after therapy, 60% to 70% of patients with acute myeloid leukemia (AML) do not survive 5 years after their initial diagnosis. The main cause of treatment failures may be insufficient eradication of a subpopulation of leuk
Autor:
Gerrit Jan Schuurhuis, Jeroen Janssen, Wendy Deenik, Walter Pouwels, Jan J. Cornelissen, Karlijn G.M. Smolders, Gert J. Ossenkoppele, Angèle Kelder, B. van Kuijk
Publikováno v:
Janssen, J J W M, Deenik, W, Smolders, K G M, van Kuijk, B J, Pouwels, W, Kelder, A, Cornelissen, J J, Schuurhuis, G J & Ossenkoppele, G J 2012, ' Residual normal stem cells can be detected in newly diagnosed chronic myeloid leukemia patients by a new flow cytometric approach and predict for optimal response to imatinib ', Leukemia, vol. 26, no. 5, pp. 977-984 . https://doi.org/10.1038/leu.2011.347
Leukemia, 26(5), 977-984. Nature Publishing Group
Leukemia, 26(5), 977-984. Nature Publishing Group
Insensitivity of chronic myeloid leukemia (CML) hematopoietic stem cells to tyrosine kinase inhibitors (TKIs) prevents eradication of the disease and may be involved in clinical resistance. For improved treatment results more knowledge about CML stem